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SUMMARY 
 
RPE65 is a protein essential for both rod- and cone-mediated vision as it regenerates 
the visual chromophore 11-cis-retinal after bleaching. In the process termed visual cycle 
RPE65 catalyzes a reaction in which bleached all-trans-retinol is isomerized to 11-cis-
retinol. The isomerized chromophore is then taken by photoreceptor cells and recombined 
with the opsin moiety to restore light sensitivity of visual pigments. Without functional 
RPE65 trans to cis isomerization is not amenable, which in patients results in complete 
blindness. To date, approximately 130 pathogenic mutations have been identified in 
RPE65. Differential clinical manifestations suggest that some patients indeed suffer from 
null mutations leading to complete loss of vision, while others retain some useful vision due 
to residual RPE65 activity. The R91W mutation is one of the most common missense 
mutations found in RPE65. Patients suffering from this mutation have some useful visual 
function early in life, however vision is completely lost later on. To understand the 
mechanism of retinal degeneration and dysfunction caused by this hypomorphic RPE65 
allele, we generated the Rpe65R91W knock-in mouse (R91W). The impact of RPE65 
insufficiency (R91W) was not only assessed in the normal, rod-dominant retina but also in 
a newly generated all-cone mouse (R91W;Nrl-/-) thereby facilitating the understanding of 
rod and cone, respectively, pathophysiological mechanisms.  
Publications presented here contributed to the field by significantly advancing the 
understanding of basic mechanisms of RPE65 physiology and it’s essential role for visual 
pigment regeneration. Our data reinforce the notion that both rod and cone photoreceptors 
depend on RPE65 for chromophore supply. We provided evidence that light acting directly 
on diseased photoreceptor can enhance progression of retinal dystrophies. The generation 
and characterization of R91W mutant mice further improved the understanding of the 
pathogenic mechanisms underlying the disease caused by RPE65 insufficiency. We 
showed that in conditions of limited chromophore supply rods and cones compete for 11-
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cis-retinal and that rods act as a sink for 11-cis-retinal depriving cones of the chromophre. 
This leads to structural destabilization of cone outer segments and a consequent cone cell 
death. This was further supported by a gene therapy approach where we showed that gene 
augmentation by the delivery of a wild type copy of the RPE65 gene led to the anatomical 
preservation of photoreceptors and the functional rescue of cone-mediated vision. After we 
have shown that the rod-dominant (R91W) mouse model indeed mimics many rod-related 
aspects of the human disease, we extended our research to the analysis of cone 
pathophysiology by developing the all-cone mouse (R91W;Nrl-/-). The main advantage of 
the R91W;Nrl-/- mouse model, as opposed to most rodent models, is that the R91W;Nrl-/- 
outer retina is composed exclusively of cones with sustained cone visual function that can 
be used to study various aspects of cone degenerations. On the basis of this mouse, we 
generated several models (inherited and induced) to study cone degeneration in the 
absence of ‘contaminating’ rods, a situation that mimics the central macula of the human 
retina. All these models are highly suitable to test potential protective strategies to treat 
cone degenerations and macular edema.  
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SUMMARY 
 
RPE65 is a protein essential for both rod- and cone-mediated vision as it regenerates 
the visual chromophore 11-cis-retinal after bleaching. In the process termed visual cycle 
RPE65 catalyzes a reaction in which bleached all-trans-retinol is isomerized to 11-cis-
retinol. The isomerized chromophore is then taken by photoreceptor cells and recombined 
with the opsin moiety to restore light sensitivity of visual pigments. Without functional 
RPE65 trans to cis isomerization is not amenable, which in patients results in complete 
blindness. To date, approximately 130 pathogenic mutations have been identified in 
RPE65. Differential clinical manifestations suggest that some patients indeed suffer from 
null mutations leading to complete loss of vision, while others retain some useful vision due 
to residual RPE65 activity. The R91W mutation is one of the most common missense 
mutations found in RPE65. Patients suffering from this mutation have some useful visual 
function early in life, however vision is completely lost later on. To understand the 
mechanism of retinal degeneration and dysfunction caused by this hypomorphic RPE65 
allele, we generated the Rpe65R91W knock-in mouse (R91W). The impact of RPE65 
insufficiency (R91W) was not only assessed in the normal, rod-dominant retina but also in 
a newly generated all-cone mouse (R91W;Nrl-/-) thereby facilitating the understanding of 
rod and cone, respectively, pathophysiological mechanisms.  
Publications presented here contributed to the field by significantly advancing the 
understanding of basic mechanisms of RPE65 physiology and it’s essential role for visual 
pigment regeneration. Our data reinforce the notion that both rod and cone photoreceptors 
depend on RPE65 for chromophore supply. We provided evidence that light acting directly 
on diseased photoreceptor can enhance progression of retinal dystrophies. The generation 
and characterization of R91W mutant mice further improved the understanding of the 
pathogenic mechanisms underlying the disease caused by RPE65 insufficiency. We 
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showed that in conditions of limited chromophore supply rods and cones compete for 11-
cis-retinal and that rods act as a sink for 11-cis-retinal depriving cones of the chromophre. 
This leads to structural destabilization of cone outer segments and a consequent cone cell 
death. This was further supported by a gene therapy approach where we showed that gene 
augmentation by the delivery of a wild type copy of the RPE65 gene led to the anatomical 
preservation of photoreceptors and the functional rescue of cone-mediated vision. After we 
have shown that the rod-dominant (R91W) mouse model indeed mimics many rod-related 
aspects of the human disease, we extended our research to the analysis of cone 
pathophysiology by developing the all-cone mouse (R91W;Nrl-/-). The main advantage of 
the R91W;Nrl-/- mouse model, as opposed to most rodent models, is that the R91W;Nrl-/- 
outer retina is composed exclusively of cones with sustained cone visual function that can 
be used to study various aspects of cone degenerations. On the basis of this mouse, we 
generated several models (inherited and induced) to study cone degeneration in the 
absence of ‘contaminating’ rods, a situation that mimics the central macula of the human 
retina. All these models are highly suitable to test potential protective strategies to treat 
cone degenerations and macular edema.  
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1. INTRODUCTION 
 
Visual pigments are composed of an opsin apo-protein linked to the chromophore 11-
cis-retinal. Visual perception begins when visual pigments of photoreceptors absorb light. 
Light absorption results in photoisomerization of the chromophore to all-trans-retinal 
causing a physical change in the opsin moiety and dissociation of all-trans-retinal from the 
opsin molecule. To restore light sensitivity the bleached opsin requires another molecule of 
11-cis-retinal, which is regenerated from all-trans-retinal in an enzymatic pathway termed 
the visual cycle (Kiser et al., 2012) (Figure1.1). Several enzymatic steps are required for 
this process, but the retinal pigment epithelial protein 65 (RPE65) is the key isomerase that 
convers all-trans-retinyl ester to 11-cis-retinol (Jin et al., 2005, Moiseyev et al., 2005, 
Redmond et al., 2005). 11-cis-retinol dehydrogenase then oxidizes 11-cis-retinol to 11-cis-
retinal (Simon et al., 1995), which is transported back to the photoreceptors and 
recombined with the opsin molecule.  
RPE65 is located in the retinal pigment epithelium (RPE) where it constitutes up to 
50% of the total microsomal proteins (Hamel et al., 1993). Although it exists as a 
membrane-bound and a soluble form (Xue et al., 2004), the interaction with the membrane 
is essential for the enzymatic activity (Nikolaeva et al., 2009). Protein sequence 
comparison revealed high evolutionary conservation of RPE65 with mouse and human 
proteins being 94% identical. The protein adopts a seven-bladed β-propeller structure as 
determined by x-ray crystallography (Kiser et al., 2009, Kiser et al., 2015) with an iron atom 
in the catalytic side coordinated by 4 conserved His residues (Poliakov et al., 2005, 
Redmond et al., 2005, Moiseyev et al., 2006). This nonheme ferrous iron is required for its 
isomerohydrolase activity (Moiseyev et al., 2006). 
Reported pathogenic mutations include missense and nonsense mutations, 
deletions, insertions as well as mutations affecting mRNA splicing (The Human Gene 
Mutation Database, http://www.hgmd.cf.ac.uk/ac/all.php). Depending on the severity of 
disease, the patients are diagnosed with fundus albipunctatus, early-onset retinal 
dystrophy, RP, or with the most severe form of inherited retinal blindness the Leber 
congenital amaurosis (LCA). Mutations in RPE65 account for 6 % of all LCA cases (den 
Hollander et al., 2008). Several animal models including the Briard dog (Aguirre et al., 
1998), and mouse lines such as rd12 (Pang et al., 2005), Rpe65-/- (Redmond et al., 1998) 
Rpe65 P25L (Li et al., 2015b) and the R91W mouse presented here (Samardzija et al., 
2008) were used to study the function of RPE65 in health and disease. These models have 
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2. RESULTS AND DISUSSION 
2.1. RPE65 AS A MODIFIER GENE FOR RETINAL DEGENERATIONS 
 
1. Wenzel, A, C Grimm, M Samardzija, and CE Reme. The genetic modifier Rpe65Leu(450): effect on 
 light damage susceptibility in c-Fos-deficient mice.  
  Invest Ophthalmol Vis Sci. 2003; 44:2798-2802. 
 
2. Wenzel, A, V Oberhauser, EN Jr Pugh, TD Lamb, C Grimm, M Samardzija, E Fahl, MW Seeliger, 
 CE Reme, and J von Lintig. The retinal G protein-coupled receptor (RGR) enhances 
 isomerohydrolase activity independent of light.  
  J Biol Chem. 2005; 280:29874-29884. 
 
3. Samardzija, M, A Wenzel, M Naash, CE Reme, and C Grimm. Rpe65 as a modifier gene for 
 inherited retinal degeneration.  
  Eur J Neurosci. 2006; 23:1028-1034. 
 
 
Life-long exposure to environmental light is implicated as cofactor important for 
progression of AMD as well as of inherited retinal degenerations in human patients 
(Margrain et al., 2004). Exposure of animal models to high levels of visible light has been 
used over years to study signaling pathways leading to retinal degeneration (reviewed in 
(Wenzel et al., 2005a)). Most importantly, excessive light induces apoptotic photoreceptor 
cell death followed by degeneration and loss of retinal function, as typically seen also in 
human retinal dystrophies. In a mouse model for Retinitis Pigmentosa (VPP) it was shown 
that that progression of a mutation-mediated retinal degeneration can be accelerated by 
light (Naash et al., 1996). This further reinforces the importance of light as an 
environmental factor influencing the severity and progression of blinding diseases.  
The articles summarized here (Wenzel et al., 2003, Wenzel et al., 2005b, Samardzija 
et al., 2006) address the consequences of a sequence variant found in the Rpe65 gene at 
position 450 and its influence on light damage susceptibility. Danciger et al. previously 
showed that this sequence variant results in an amino acid substitution at position 450 
(Leu450Met) in RPE65 and leads to increased resistance against acute light damage 
resulting in reduced photoreceptor loss in B6 mice (Danciger et al., 2000). We analyzed 
this variant in a mouse model lacking c-fos to investigate the significance of Danciger’s 
finding. c-fos was one of the first identified genes that are crucial for light-induced retinal 
degeneration as its absence confers resistance against light damage (Hafezi et al., 1997). 
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We showed that replacing the Met450 variant of Rpe65 by the Leu450 variant in c-fos 
knock out mice resulted in increased levels of RPE65 protein, accelerated rhodopsin 
regeneration and restored light damage susceptibility. This showed that the Leu450 variant 
is sufficient to overcome the protection against light-induced damage conferred by absence 
of c-fos. Light induced retinal degeneration models served during the years as platforms to 
test neuroprotective compounds (Wenzel et al., 2005a). Understanding that Met450 variant 
leads to slower chromophore synthesis, which increases retinal resistance to light damage 
(Wenzel et al., 2003, Wenzel et al., 2005b) is important, as genetically modified mouse 
models are very commonly on a B6 background with the light-resistant Rpe65 variant. 
Therefore, such models have to be used cautiously when employed to assess potential 
therapeutic agents against light-induced degeneration of photoreceptors. 
Most importantly we showed (Samardzija et al., 2006) that increased absorption of photons 
and light sensitivity, conferred by the Leu450 variant, further accelerates retinal 
degeneration in the VPP mouse, a genetic model for Retinitis Pigmentosa (Figure 2.1, 
(Samardzija et al., 2006)). This suggested that sequence variations in the RPE65 gene 
could act as genetic modifiers in inherited retinal degenerations, presumably by regulating 
the daily rate of photon absorption through the modulation of rhodopsin regeneration 
kinetics. It is interesting to note that humans are exclusively carrying Leu450 variant and 
that no pathogenic mutation was identified on that amino acid residue. A recently reported 
mouse model carrying a human P25L missense mutation in Rpe65 (Li et al., 2015b) shows 
also resistance to light-induced retinal damage due to the reduced expression and catalytic 
activity of the mutant RPE65. This is consistent to our notion of the importance of RPE65 
as a potential modulator responsible for variations in disease progression.  
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Figure 2.1. RPE65 Leu450 variant accelerates progression of retinal degeneration in a mouse 
 model for Retinitis Pigmentosa.  
Time course of VPP-mediated retinal degeneration was dependent on the Rpe65 sequence. (A) Retinal 
morphology of VPP;Rpe65450Met (left column), VPP;Rpe65450Leu (middle column) and wt;Rpe65450Leu 
(right column) mice at PND 11 (top row), 15 (middle row) and 18 (bottom row). Shown are representative 
sections of the lower temporal part of at three or more independent mice. (B) Retinal morphology of 
VPP;Rpe65450Met (left column), VPP;Rpe65450Leu (middle column) and Rpe65-/-(right column) mice at 
PND 21 (top row), 28 (second row), 42 (third row) and 56 (bottom row). The Rpe65450Leu variant 
accelerated the VPP- mediated retinal degeneration leading to a more pronounced thinning of the ONL and 
less preserved photoreceptor segments. The Rpe65 knockout only partially rescued the degeneration. Shown 
are representative sections of the lower temporal part of at least three independent mice. (C) Rhodopsin per 
retina expressed in nmol. Values are given as means + SD. Open bars, VPP;Rpe65450Met; solid bars, 
VPP;Rpe65450Leu. Numbers of mice are indicated. *P < 0.0046, **P < 0.0001. (D) Representative section 
through the lower temporal part of the retina of an Rpe65-/- mouse at PND 56. PS, photoreceptor segment; 
ONL, outer nuclear layer; INL, inner nuclear layer. (Samardzija et al., 2006) 
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2.2. THE PATHOGENIC R91W MUTATION IN RPE65 IN THE ROD-DOMINANT 
RETINA 
 
4. Samardzija, M, J von Lintig, N Tanimoto, V Oberhauser, M Thiersch, CE Reme, M Seeliger, C 
 Grimm, and A Wenzel. R91W mutation in Rpe65 leads to milder early-onset retinal 
 dystrophy due to the generation of low levels of 11-cis-retinal.  
  Hum Mol Genet. 2008; 17:281-292. 
 
5. Samardzija, M, N Tanimoto, C Kostic, S Beck, V Oberhauser, S Joly, M Thiersch, E Fahl, Y 
 Arsenijevic, J von Lintig, A Wenzel, MW Seeliger, and C Grimm. In conditions of limited 
 chromophore supply rods entrap 11-cis-retinal leading to loss of cone function and cell death. 
 Hum Mol Genet. 2009; 18:1266-1275. 
 
6. Kostic, C, SV Crippa, V Pignat, AP Bemelmans, M Samardzija, C Grimm, A Wenzel, and Y 
 Arsenijevic. Gene therapy regenerates protein expression in cone photoreceptors in 
 Rpe65(R91W/R91W) mice.  
  PLoS One. 2011; 6:e16588. 
 
 
Mutations in RPE65 lead to autosomal recessive dystrophies ranging from Retinitis 
Pigmentosa to Lebers congenital amaurosis (Marlhens et al., 1997, Morimura et al., 1998). 
Missense mutations account for more than 60 % of all disease-associated mutations 
identified in the RPE65 gene (128 reported to date). The pathogenic mechanisms for most 
of these mutations are still poorly understood. Recently, however, an in vitro analysis of 
several disease-associated mutations showed that protein misfolding and a rapid 
proteasomal degradation might be the pathogenic mechanism leading to blindness (Li et 
al., 2014, Li et al., 2015a).  
Codon 91 encoding arginine (R) seems to be prone to amino acid changes as three 
pathogenic missense mutations have been reported in RPE65 patients at that position: 
R91W (Morimura et al., 1998), R91Q (Thompson et al., 2000) and R91P (Simonelli et al., 
2007)). Remarkably, the R91W substitution in RPE65 is the most frequent missense 
mutation found in patients in general. While R91Q and R91P patients are congenitally 
blind, patients carrying R91W mutation have useful cone-mediated vision in the first 
decade of life (El Matri et al., 2006). However, vision is completely lost in the third decade 
of life. Mice lacking RPE65 (Rpe65-/- and rd12 mice) cannot synthesize 11-cis-retinoids, 
and thus present a different situation as found in patients where data suggested that some 
missense mutations produced versions of RPE65 with some residual enzymatic activity. To 
generate a mouse model that resembles the human conditions more closely, we generated 
R91W knock-in mice. These mice were used to investigate the pathophysiological 
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mechanisms of retinal degeneration caused by aberrant RPE65 function. The mutation 
caused low expression levels and reduced function of the mutant RPE65 protein in the 
RPE (Samardzija et al., 2008). Consistent with the predicted diminished enzymatic activity 
of mutant RPE65R91W in patients, the R91W mice exhibit very low chromophore (11-cis-
retinal) levels in the retina - accounting for less than 10% of wild-type levels. As a result of 
this hypomorphic RPE65 activity, rods are desensitized which leads to a severely 
compromised visual function. Our data indicated that the R91W mouse is highly suitable to 
study the impact of RPE65 insufficiency on rod pathophysiology. This work for the first time 
explained the molecular basis for differences in visual performances between RPE65 
patients.  
The follow up study (Samardzija et al., 2009) focused on the consequences of the 
R91W mutation for cone structure and function. Previous work on Rpe65-/- mice showed 
that cones are especially sensitive to the lack of 11-cis-retinal, which results in fast cone 
degeneration (Znoiko et al., 2005). As 11-cis-retinal is used as chromophore by both cones 
and rods, we analyzed the photoreceptor type to which the remnant visual function in 
R91W mice was attributed. We showed that limited retinal levels of 11-cis-retinal is 
especially unfavorable for the cones, which undergo a slow but progressive degeneration 
with a geographic prevalence. This was shown with a variety of techniques including a 
longitudinal in vivo study where we visualized GFP-expressing cone cells using a scanning 
laser ophthalmoscope (Samardzija et al., 2009). As a consequence of insufficient 
chromophore supply, most chromophore is trapped by the very abundant rod opsin leaving 
cone opsin ‘naked’. This results in cone opsin mislocalization in the R91W retina. Since 
cone opsin is an important structural element for the cells this leads to cone degeneration 
and consequent loss of cone-mediated vision. This is consistent with data from RPE65 
patients showing that peripheral cones, which are surrounded by rods as in the mouse 
retina, are much earlier affected than central cones in the rod-free foveola (Bonilha et al., 
2011). The proof that rods act as chromophore ‘sink’ was provided by the ablation of rod 
opsin, which prevented cone opsin mislocalization and restored cone function in R91W 
animals (Figure 2.2, (Samardzija et al., 2009)). Collectively our data indicated that under 
conditions of limited chromophore supply rods entrap most of the available 11-cis-retinal 
leaving insufficient chromophore for an efficient cone function and cone survival. The 
identified competition between rods and cones for the visual chromophore suggests that it 
may be important to deliver a functional RPE65 gene directly to the cone-rich macula in 
patients in order to avoid the strong rod chromophore trap. In addition, the fact that cones 
are especially sensitive to chromophore starvation adds a cautionary note to therapeutic 
approaches using a pharmacological inhibition of chromophore regeneration in order to 
reduce retinal degeneration. Such approaches may not only impair night vision of patients 
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but may also have negative effects on cone integrity and thus cone- mediated vision in the 
long-run. 
In the follow up gene therapy study (Kostic et al., 2011) we showed that lentiviral 
vector delivery of RPE65 rescues cone photoreceptors and prevents cone degeneration in 
R91W mice. Importantly we showed that the delivered wild type copy of RPE65 
rejuvenates cones that had already completely or partially lost the expression of 
phototransduction proteins and marker proteins of cone outer segments, respectively. The 
lentiviral therapy leads to long-lasting transgene expression in the RPE cells and improved 
retinal function. We evaluated the therapeutic window within which cones can be rescued 
in the R91W mouse and showed that this window is extended as compared to the Rpe65-/- 
mice (Bemelmans et al., 2006). This finding has a direct clinical relevance for the gene 
therapy of the patients.   
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Figure 2.2. Under conditions of limited chromophore supply rods act as a sink and deprive cones 
 form chromophore 
Effect of the R91W mutation on retinal function. Evaluation of retinal function by electroretinogram 
(ERG) of 4-week-old wt, R91W, rho-/-, R91W;rho-/-, R91W;Gnat1a-/-, R91W;Gnat1a-/-; rho-/- and Rpe65-/-;rho-/- 
mice. Single flash ERGs were recorded under dark-adapted (A, scotopic) and light-adapted (B, photopic) 
conditions. Additional deletion of rhodopsin in R91W and Rpe65-/- enabled the examination of pure cone 
function in the absence of the rod system. The vertical lines indicate the time point of the light flash. Note that 
an initial negative deflection in the higher intensity range (above 1.5 log cd*s/m2) is not a retinal electrical 
response but a flash artifact. (Samardzija et al., 2009) 
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2.3. THE R91W MUTATION IN RPE65 AND CONES 
 
7. Samardzija, M, C Caprara, SR Heynen, S Willcox DeParis, I Meneau, G Traber, C Agca, J von 
 Lintig, and C Grimm. A mouse model for studying cone photoreceptor pathologies. Invest 
 Ophthalmol Vis Sci. 2014; 55:5304-5313. 
 
8. Geiger, P, M Barben, C Grimm, and M Samardzija. Blue light-induced retinal lesions, intraretinal 
 vascular leakage and edema formation in the all-cone mouse retina.  
  Cell Death Dis. accepted; 
 
 
Considering that the rod-cone ratio in the human macula is much in favor of cones, 
with the central fovea lacking rods altogether, the results obtained in the rod-dominated 
retinas of R91W mice phenocopy the situation in the peripheral but not central retina of 
patients. To generate a model that is suited to study the impact of the R91W mutation on 
cones in the central macula, we combined the R91W with the Nrl-/- mouse (Mears et al., 
2001). The Nrl-/- mice lack the neural retina leucine zipper (NRL) transcription factor, 
necessary to direct photoreceptor progenitor cells towards the rod cell fate. Nrl-/- retinas are 
overpopulated with an excess of cone photoreceptors and lack rods completely. Therefore, 
the retina of R91W;Nrl-/- double mutant mice mimics the situation in the central, cone-rich, 
rod-free retina of human patients suffering from a hypomorphic RPE65 function. 
Importantly, cones of R91W;Nrl-/- mice are functional and show a strong photopic activity. 
We showed that despite the severely reduced amount of chromophore in R91W;Nrl-/- mice, 
the cones survive much longer in such a cone-only environment than in the rod-dominant 
retina of R91W mice (Samardzija et al., 2014). This is consistent with the prolonged 
survival of foveal cones in RPE65 patients and suggests that the R91W and the R91W;Nrl-/- 
mouse lines are genuine models to study human pathologies caused by the Rpe65R91W 
mutation in the peripheral and the central retina, respectively.  
To investigate the molecular fingerprint of cone degenerations we further generated 
mutation-mediated (inherited) cone degeneration models by crossing R91W;Nrl-/- mice with 
Cpfl1 (Chang et al., 2002) and rd10 (Chang et al., 2002) mice resulting in triple and 
quadruple mutant mice, respectively. While triple mutant R91W;Nrl-/-;Cpfl1 mice still had a 
good retinal function, retinas of quadruple mutant R91W;Nrl-/-;Cpfl1;rd10 mice were devoid 
of function. All mice exhibited a degeneration of the cells in the outer nucler layer, albeit 
with different kinetics and severities. The quadruple mutant mice showed the most severe 
degeneration, the triple mutant mouse an intermediate degeneration and the original 
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R91W;Nrl-/- mouse had the slowest degeneration kinetics. The comparative study of 
degenerations in these models is currently under thorough investigation in the laboratory 
aiming at the identification of the molecular pathways responsible for cone cell death.  
In the final study (Geiger et al., accepted) the consequences of exposure to toxic 
levels of blue light for the all-cone retina were analyzed. It is important to note that 
R91W;Nrl-/- mice are resistant to standard light damage protocols that use high levels of 
white fluorescent light. As expected from the studies described above, reduced levels of 
RPE65R91W protein together with extremely low chromophore yield (Samardzija et al., 2008) 
renders R91W;Nrl-/- resistant to white light. In contrast to white light, blue light strongly 
damaged R91W;Nrl-/- retinas. In general, light of shorter wavelengths is more harmful to the 
retina than long wavelength light. It has been clearly demonstrated in rodents, rabbits and 
monkey that the damage threshold correlates with the wavelength of light used for 
exposure: the shorter the wavelength, the lower the threshold (van Norren and Gorgels, 
2011). Furthermore, R91W;Nrl-/- retinas are overpopulated with short wavelength cones 
which absorb light maximally in the UV range at 360 nm, which is close to the wavelength 
of the damaging blue light used in the study (410 nm). In addition, blue light triggers 
photochemical regeneration of bleachable rhodopsin on site – in the photoreceptor outer 
segments – without the involvement of metabolic regeneration via the visual cycle and RPE 
(Williams, 1964). This process – termed photoreversal of bleaching – leads to a dramatic 
increase in the photon catch capacity by the visual pigment in blue light conditions (Grimm 
et al., 2000). In the wild-type rod-dominant mouse retinas blue light induced predominantly 
the loss of rod photoreceptor cells and disruption of the outer retinal blood barrier that is 
composed of RPE cells in retina. We showed that toxic levels of blue light in R91W;Nrl-/- 
mice not only induces cone photoreceptor death but also affects other cells especially of 
the inner retina and causes a strong microglial response as well as neuroinflammation. We 
found strongly increased levels of Tnf and Il1b in the all-cone retinas of R91W;Nrl-/- as 
compared to wt. It is important to note that microglial activation impairs blood brain barrier 
function by the release of various proinflammatory factors, including TNF and IL1B, shown 
to enhance retinal vascular permeability (Abcouwer et al., 2013) but also hyperpermeability 
associated with neurodegenerative disorders such as Alzheimers disease and multiple 
sclerosis (reviewed in (da Fonseca et al., 2014). Upregulation of Tnf and Il1b expression in 
response to blue light exposure was paralleled by vessel leakage leading to retinal 
hemorrhages, suggesting that the inner retinal blood barrier was affected in the all-cone 
retina. We also provide evidence for a strong edema formation after the light insult in 
R91W;Nrl-/- mice (Figure 2.3; (Geiger et al., accepted)). Diabetic macular edema is 
characterized by low-grade inflammatory reaction, a blood-retinal barrier breakdown and 
retinal capillary leakage (Klaassen et al., 2013). Thus blue light damage in R91W;Nrl-/- mice 
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can be used to test potential therapeutic agents for the treatment of edema-based 
complications in macular degenerations. 
 
 
Figure 2.3. R91W;Nrl-/- as a model for macular edema 
Fundus (color) and corresponding OCT (black and white) images of wt (a, d) and R91W;Nrl-/- (b, e) 
mice taken up to 10 days following blue light damage (BLD). The positions of the OCT scans are shown in 
fundi as colored circles/lines (green, superior; red, inferior). At 2 and 3 days after BLD the hot spot regions 
appeared as a pale bluish spot, much lighter than the rest of the fundus (a, b). OCT revealed that INL and ONL 
in the damaged (inferior) but not the control area (superior) became hyperreflective in wt; while 
hyperreflectivity was very pronounced in the IPL but absent in the ONL in R91W;Nrl-/- mice. Boxed panels in 
(a) and (b) show linear scans of the transition zones analyzed 3 days following BLD. Increased retinal 
thickness was especially prominent in R91W;Nrl-/- mice. Quantification of retinal thickness in R91W;Nrl-/- and 
wt eyes that were unexposed (ctrl) or exposed to blue light, as indicated (c). Values are expressed relative to 
the mean value of unexposed wt mice that was set to 1. N = 4 (wt) or 5 (R91W;Nrl-/-); *P<0.05; ***P<0.001). 
At 10 days after BLD the hot spot regions can be recognized by whitish material appearing in the fundus and 
by a thinned retina in OCT (d, e). Note: The 2 d and 3 d time points in panels (a) and (b) show data from the 
same mouse followed for two consecutive days. Scale bars 100 µm. (Geiger et al., accepted) 
   HABILITATIONSSCHRIFT M. SAMARDZIJA 
17 
 
 
CONCLUSION  
 
Currently, no therapies are available to prevent photoreceptor death. This is partially 
due to a limited knowledge of the mechanisms by which photoreceptor cells die. Even less 
is known about specific mechanisms of cone degeneration in age related-macular 
degeneration. Our research, which started with experiments aiming to understand the basic 
role of RPE65 in the visual cycle, led us to the development of R91W and R91W;Nrl-/- 
mouse models. While the R91W single mutant mouse served as a base for understanding 
pathogenic mechanisms underlying RPE65 insufficiency, the R91W;Nrl-/- double mutant 
mouse allowed the investigation of the consequences of disease causing cone-specific 
mutations in an organized all-cone environment. The R91W;Nrl-/- mice are especially suited 
for neuroprotective studies, gene therapy approaches and for cone cell transplantation 
experiments to rescue cone vision. Several research groups already acquired the R91W 
and R91W;Nrl-/- mouse lines for projects such as in-depth analysis of RPE65R91W 
biochemistry (M. Jin, LSU Health Sciences Center School of Medicine, New Orleans, US); 
MRI imaging of cone physiology (B. Berkowitz, Wayne State University, Detroit, US); cone 
transplantation approaches (R. Ali, University College London, UK); electrophysiology of 
synaptic transmission in cone photoreceptors (S. Baker, University of Iowa; US). Thus, the 
mice will significantly accelerate cone related research and the collection of data needed to 
develop successful therapeutic strategies to treat cone related retinal degenerations in 
human patients. 
  
   HABILITATIONSSCHRIFT M. SAMARDZIJA 
 18 
 
REFERENCES 
 
Abcouwer, S. F., Lin, C. M., Shanmugam, S., Muthusamy, A., Barber, A. J.,Antonetti, D. A., 2013. 
Minocycline prevents retinal inflammation and vascular permeability following ischemia-
reperfusion injury. J Neuroinflammation 10, 149. 
Aguirre, G. D., Baldwin, V., Pearce-Kelling, S., Narfstrom, K., Ray, K.,Acland, G. M., 1998. 
Congenital stationary night blindness in the dog: common mutation in the RPE65 gene 
indicates founder effect. Mol Vis 4, 23. 
Bainbridge, J. W., Mehat, M. S., Sundaram, V., Robbie, S. J., Barker, S. E., Ripamonti, C., 
Georgiadis, A., Mowat, F. M., Beattie, S. G., Gardner, P. J., Feathers, K. L., Luong, V. A., 
Yzer, S., Balaggan, K., Viswanathan, A., de Ravel, T. J., Casteels, I., Holder, G. E., Tyler, N., 
Fitzke, F. W., Weleber, R. G., Nardini, M., Moore, A. T., Thompson, D. A., Petersen-Jones, S. 
M., Michaelides, M., van den Born, L. I., Stockman, A., Smith, A. J., Rubin, G.,Ali, R. R., 2015. 
Long-term effect of gene therapy on Leber's congenital amaurosis. N Engl J Med 372, 1887-
1897. 
Bainbridge, J. W., Smith, A. J., Barker, S. S., Robbie, S., Henderson, R., Balaggan, K., 
Viswanathan, A., Holder, G. E., Stockman, A., Tyler, N., Petersen-Jones, S., Bhattacharya, S. 
S., Thrasher, A. J., Fitzke, F. W., Carter, B. J., Rubin, G. S., Moore, A. T.,Ali, R. R., 2008. 
Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358, 
2231-2239. 
Bemelmans, A. P., Kostic, C., Crippa, S. V., Hauswirth, W. W., Lem, J., Munier, F. L., Seeliger, M. 
W., Wenzel, A.,Arsenijevic, Y., 2006. Lentiviral gene transfer of RPE65 rescues survival and 
function of cones in a mouse model of Leber congenital amaurosis. PLoS Med 3, e347. 
Bonilha, V. L., Rayborn, M. E., Li, Y., Grossman, G. H., Berson, E. L.,Hollyfield, J. G., 2011. 
Histopathology and functional correlations in a patient with a mutation in RPE65, the gene for 
retinol isomerase. Invest Ophthalmol Vis Sci 52, 8381-8392. 
Chang, B., Hawes, N. L., Hurd, R. E., Davisson, M. T., Nusinowitz, S.,Heckenlively, J. R., 2002. 
Retinal degeneration mutants in the mouse. Vision Res 42, 517-525. 
Cideciyan, A. V., Aleman, T. S., Boye, S. L., Schwartz, S. B., Kaushal, S., Roman, A. J., Pang, J. J., 
Sumaroka, A., Windsor, E. A., Wilson, J. M., Flotte, T. R., Fishman, G. A., Heon, E., Stone, E. 
M., Byrne, B. J., Jacobson, S. G.,Hauswirth, W. W., 2008. Human gene therapy for RPE65 
isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl 
Acad Sci U S A 105, 15112-15117. 
Cideciyan, A. V., Jacobson, S. G., Beltran, W. A., Sumaroka, A., Swider, M., Iwabe, S., Roman, A. 
J., Olivares, M. B., Schwartz, S. B., Komaromy, A. M., Hauswirth, W. W.,Aguirre, G. D., 2013. 
Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal 
degeneration despite enduring visual improvement. Proc Natl Acad Sci U S A 110, E517-25. 
REFERENCES   HABILITATIONSSCHRIFT M. SAMARDZIJA 
 19 
da Fonseca, A. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C.,Lima, F. R., 2014. 
The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell 
Neurosci 8, 362. 
Danciger, M., Matthes, M. T., Yasamura, D., Akhmedov, N. B., Rickabaugh, T., Gentleman, S., 
Redmond, T. M., La Vail, M. M.,Farber, D. B., 2000. A QTL on distal chromosome 3 that 
influences the severity of light-induced damage to mouse photoreceptors. Mamm Genome 11, 
422-427. 
den Hollander, A. I., Roepman, R., Koenekoop, R. K.,Cremers, F. P., 2008. Leber congenital 
amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res 27, 391-419. 
El Matri, L., Ambresin, A., Schorderet, D. F., Kawasaki, A., Seeliger, M. W., Wenzel, A., Arsenijevic, 
Y., Borruat, F. X.,Munier, F. L., 2006. Phenotype of three consanguineous Tunisian families 
with early-onset retinal degeneration caused by an R91W homozygous mutation in the RPE65 
gene. Graefes Arch Clin Exp Ophthalmol 244, 1104-1112. 
Geiger, P., Barben, M., Grimm, C.,Samardzija, M., accepted. Blue light-induced retinal lesions, 
intraretinal vascular leakage and edema formation in the all-cone mouse retina. Cell Death Dis  
Grimm, C., Reme, C. E., Rol, P. O.,Williams, T. P., 2000. Blue light's effects on rhodopsin: 
photoreversal of bleaching in living rat eyes. Invest Ophthalmol Vis Sci 41, 3984-3990. 
Hafezi, F., Steinbach, J. P., Marti, A., Munz, K., Wang, Z. Q., Wagner, E. F., Aguzzi, A.,Reme, C. E., 
1997. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in 
retinal degeneration in vivo. Nat Med 3, 346-349. 
Hamel, C. P., Tsilou, E., Harris, E., Pfeffer, B. A., Hooks, J. J., Detrick, B.,Redmond, T. M., 1993. A 
developmentally regulated microsomal protein specific for the pigment epithelium of the 
vertebrate retina. J Neurosci Res 34, 414-425. 
Hauswirth, W., Aleman, T. S., Kaushal, S., Cideciyan, A. V., Schwartz, S. B., Wang, L., Conlon, T., 
Boye, S. L., Flotte, T. R., Byrne, B.,Jacobson, S. G., 2008. Phase I Trial of Leber Congenital 
Amaurosis due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus 
Gene Vector: Short-Term Results. Hum Gene Ther In press. 
Jin, M., Li, S., Moghrabi, W. N., Sun, H.,Travis, G. H., 2005. Rpe65 is the retinoid isomerase in 
bovine retinal pigment epithelium. Cell 122, 449-459. 
Kiser, P. D., Golczak, M., Lodowski, D. T., Chance, M. R.,Palczewski, K., 2009. Crystal structure of 
native RPE65, the retinoid isomerase of the visual cycle. Proc Natl Acad Sci U S A 106, 
17325-17330. 
Kiser, P. D., Golczak, M., Maeda, A.,Palczewski, K., 2012. Key enzymes of the retinoid (visual) cycle 
in vertebrate retina. Biochim Biophys Acta 1821, 137-151. 
Kiser, P. D., Zhang, J., Badiee, M., Li, Q., Shi, W., Sui, X., Golczak, M., Tochtrop, G. P.,Palczewski, 
K., 2015. Catalytic mechanism of a retinoid isomerase essential for vertebrate vision. Nat 
Chem Biol 11, 409-415. 
Klaassen, I., Van Noorden, C. J.,Schlingemann, R. O., 2013. Molecular basis of the inner blood-
retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. 
Prog Retin Eye Res 34, 19-48. 
REFERENCES   HABILITATIONSSCHRIFT M. SAMARDZIJA 
 20 
Kostic, C., Crippa, S. V., Pignat, V., Bemelmans, A. P., Samardzija, M., Grimm, C., Wenzel, 
A.,Arsenijevic, Y., 2011. Gene therapy regenerates protein expression in cone photoreceptors 
in Rpe65(R91W/R91W) mice. PLoS One 6, e16588. 
Li, S., Hu, J., Jin, R. J., Aiyar, A., Jacobson, S. G., Bok, D.,Jin, M., 2015a. Temperature-sensitive 
retinoid isomerase activity of RPE65 mutants associated with Leber Congenital Amaurosis. J 
Biochem 158, 115-125. 
Li, S., Izumi, T., Hu, J., Jin, H. H., Siddiqui, A. A., Jacobson, S. G., Bok, D.,Jin, M., 2014. Rescue of 
enzymatic function for disease-associated RPE65 proteins containing various missense 
mutations in non-active sites. J Biol Chem 289, 18943-18956. 
Li, Y., Yu, S., Duncan, T., Li, Y., Liu, P., Gene, E., Cortes-Pena, Y., Qian, H., Dong, L.,Redmond, T. 
M., 2015b. Mouse model of human RPE65 P25L hypomorph resembles wild type under 
normal light rearing but is fully resistant to acute light damage. Hum Mol Genet 24, 4417-4428. 
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N. J., Mingozzi, F., Bennicelli, J., Banfi, S., 
Marshall, K. A., Testa, F., Surace, E. M., Rossi, S., Lyubarsky, A., Arruda, V. R., Konkle, B., 
Stone, E., Sun, J., Jacobs, J., Dell'Osso, L., Hertle, R., Ma, J. X., Redmond, T. M., Zhu, X., 
Hauck, B., Zelenaia, O., Shindler, K. S., Maguire, M. G., Wright, J. F., Volpe, N. J., McDonnell, 
J. W., Auricchio, A., High, K. A.,Bennett, J., 2008. Safety and efficacy of gene transfer for 
Leber's congenital amaurosis. N Engl J Med 358, 2240-2248. 
Margrain, T. H., Boulton, M., Marshall, J.,Sliney, D. H., 2004. Do blue light filters confer protection 
against age-related macular degeneration? Prog Retin Eye Res 23, 523-531. 
Marlhens, F., Bareil, C., Griffoin, J. M., Zrenner, E., Amalric, P., Eliaou, C., Liu, S. Y., Harris, E., 
Redmond, T. M., Arnaud, B., Claustres, M.,Hamel, C. P., 1997. Mutations in RPE65 cause 
Leber's congenital amaurosis. Nat Genet 17, 139-141. 
Mears, A. J., Kondo, M., Swain, P. K., Takada, Y., Bush, R. A., Saunders, T. L., Sieving, P. 
A.,Swaroop, A., 2001. Nrl is required for rod photoreceptor development. Nat Genet 29, 447-
452. 
Moiseyev, G., Chen, Y., Takahashi, Y., Wu, B. X.,Ma, J. X., 2005. RPE65 is the isomerohydrolase in 
the retinoid visual cycle. Proc Natl Acad Sci U S A 102, 12413-12418. 
Moiseyev, G., Takahashi, Y., Chen, Y., Gentleman, S., Redmond, T. M., Crouch, R. K.,Ma, J. X., 
2006. RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle. J Biol 
Chem 281, 2835-2840. 
Morimura, H., Fishman, G. A., Grover, S. A., Fulton, A. B., Berson, E. L.,Dryja, T. P., 1998. 
Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or 
leber congenital amaurosis. Proc Natl Acad Sci U S A 95, 3088-3093. 
Naash, M. L., Peachey, N. S., Li, Z. Y., Gryczan, C. C., Goto, Y., Blanks, J., Milam, A. H.,Ripps, H., 
1996. Light-induced acceleration of photoreceptor degeneration in transgenic mice expressing 
mutant rhodopsin. Invest Ophthalmol Vis Sci 37, 775-782. 
Nikolaeva, O., Takahashi, Y., Moiseyev, G.,Ma, J. X., 2009. Purified RPE65 shows 
isomerohydrolase activity after reassociation with a phospholipid membrane. FEBS J 276, 
3020-3030. 
REFERENCES   HABILITATIONSSCHRIFT M. SAMARDZIJA 
 21 
Pang, J. J., Chang, B., Hawes, N. L., Hurd, R. E., Davisson, M. T., Li, J., Noorwez, S. M., Malhotra, 
R., McDowell, J. H., Kaushal, S., Hauswirth, W. W., Nusinowitz, S., Thompson, D. 
A.,Heckenlively, J. R., 2005. Retinal degeneration 12 (rd12): a new, spontaneously arising 
mouse model for human Leber congenital amaurosis (LCA). Mol Vis 11, 152-162. 
Poliakov, E., Gentleman, S., Cunningham, F. X., Jr., Miller-Ihli, N. J.,Redmond, T. M., 2005. Key role 
of conserved histidines in recombinant mouse beta-carotene 15,15'-monooxygenase-1 
activity. J Biol Chem 280, 29217-29223. 
Redmond, T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma, J. X., Crouch, R. 
K.,Pfeifer, K., 1998. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual 
cycle. Nat Genet 20, 344-351. 
Redmond, T. M., Poliakov, E., Yu, S., Tsai, J. Y., Lu, Z.,Gentleman, S., 2005. Mutation of key 
residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle. Proc 
Natl Acad Sci U S A 102, 13658-13663. 
Saari, J. C., 2001. The sights along route 65. Nat Genet 29, 8-9. 
Samardzija, M., Caprara, C., Heynen, S. R., Willcox DeParis, S., Meneau, I., Traber, G., Agca, C., 
von Lintig, J.,Grimm, C., 2014. A mouse model for studying cone photoreceptor pathologies. 
Invest Ophthalmol Vis Sci 55, 5304-5313. 
Samardzija, M., Tanimoto, N., Kostic, C., Beck, S., Oberhauser, V., Joly, S., Thiersch, M., Fahl, E., 
Arsenijevic, Y., von Lintig, J., Wenzel, A., Seeliger, M. W.,Grimm, C., 2009. In conditions of 
limited chromophore supply rods entrap 11-cis-retinal leading to loss of cone function and cell 
death. Hum Mol Genet 18, 1266-1275. 
Samardzija, M., von Lintig, J., Tanimoto, N., Oberhauser, V., Thiersch, M., Reme, C. E., Seeliger, 
M., Grimm, C.,Wenzel, A., 2008. R91W mutation in Rpe65 leads to milder early-onset retinal 
dystrophy due to the generation of low levels of 11-cis-retinal. Hum Mol Genet 17, 281-292. 
Samardzija, M., Wenzel, A., Naash, M., Reme, C. E.,Grimm, C., 2006. Rpe65 as a modifier gene for 
inherited retinal degeneration. Eur J Neurosci 23, 1028-1034. 
Simon, A., Hellman, U., Wernstedt, C.,Eriksson, U., 1995. The retinal pigment epithelial-specific 11-
cis retinol dehydrogenase belongs to the family of short chain alcohol dehydrogenases. J Biol 
Chem 270, 1107-1112. 
Simonelli, F., Ziviello, C., Testa, F., Rossi, S., Fazzi, E., Bianchi, P. E., Fossarello, M., Signorini, S., 
Bertone, C., Galantuomo, S., Brancati, F., Valente, E. M., Ciccodicola, A., Rinaldi, E., 
Auricchio, A.,Banfi, S., 2007. Clinical and molecular genetics of Leber's congenital amaurosis: 
a multicenter study of Italian patients. Invest Ophthalmol Vis Sci 48, 4284-4290. 
Thompson, D. A., Gyurus, P., Fleischer, L. L., Bingham, E. L., McHenry, C. L., Apfelstedt-Sylla, E., 
Zrenner, E., Lorenz, B., Richards, J. E., Jacobson, S. G., Sieving, P. A.,Gal, A., 2000. 
Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest 
Ophthalmol Vis Sci 41, 4293-4299. 
van Norren, D.,Gorgels, T. G., 2011. The action spectrum of photochemical damage to the retina: a 
review of monochromatic threshold data. Photochem Photobiol 87, 747-753. 
REFERENCES   HABILITATIONSSCHRIFT M. SAMARDZIJA 
 22 
Wenzel, A., Grimm, C., Samardzija, M.,Reme, C. E., 2005a. Molecular mechanisms of light-induced 
photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res 24, 
275-306. 
Wenzel, A., Grimm, C., Samardzija, M.,Reme, C. E., 2003. The genetic modifier Rpe65Leu(450): 
effect on light damage susceptibility in c-Fos-deficient mice. Invest Ophthalmol Vis Sci 44, 
2798-2802. 
Wenzel, A., Oberhauser, V., Pugh, E. N., Jr., Lamb, T. D., Grimm, C., Samardzija, M., Fahl, E., 
Seeliger, M. W., Reme, C. E.,von Lintig, J., 2005b. The retinal G protein-coupled receptor 
(RGR) enhances isomerohydrolase activity independent of light. J Biol Chem 280, 29874-
29884. 
Williams, T. P., 1964. Photoreversal of rhodopsin bleaching. J Gen Physiol 47, 679-689. 
Xue, L., Gollapalli, D. R., Maiti, P., Jahng, W. J.,Rando, R. R., 2004. A palmitoylation switch 
mechanism in the regulation of the visual cycle. Cell 117, 761-771. 
Znoiko, S. L., Rohrer, B., Lu, K., Lohr, H. R., Crouch, R. K.,Ma, J. X., 2005. Downregulation of cone-
specific gene expression and degeneration of cone photoreceptors in the Rpe65-/- mouse at 
early ages. Invest Ophthalmol Vis Sci 46, 1473-1479. 
 
 
